These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 6274810)
1. Establishment of human cytotoxic T-cell lines specific for Epstein-Barr virus-transformed autologous cells. Sugamura K; Tanaka Y; Hinuma Y Int J Cancer; 1981 Aug; 28(2):137-42. PubMed ID: 6274810 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus. Tanaka Y; Sugamura K; Hinuma Y J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428 [TBL] [Abstract][Full Text] [Related]
3. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen. Hank JA; Sondel PM Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468 [TBL] [Abstract][Full Text] [Related]
4. Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation method. Tanaka Y; Sugamura K; Hinuma Y; Sato H; Okochi K J Immunol; 1980 Oct; 125(4):1426-31. PubMed ID: 6157733 [TBL] [Abstract][Full Text] [Related]
5. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules. Chen BP; DeMars R; Hank JA; Sondel PM Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068 [TBL] [Abstract][Full Text] [Related]
6. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line. Fukukawa T; Hirano T; Sakaguchi N; Teranishi T; Tsuyuguchi I; Nagao N; Naito N; Yoshimura K; Okubo Y; Tohda H; Oikawa A J Immunol; 1981 May; 126(5):1697-701. PubMed ID: 6163815 [TBL] [Abstract][Full Text] [Related]
7. T cell growth factor from human splenic cell cultures: conditions for its production, and its utilization for maintenance of cytotoxic T cell lines. Tanaka Y; Sugamura K; Hinuma Y Microbiol Immunol; 1981; 25(10):1077-86. PubMed ID: 6273698 [TBL] [Abstract][Full Text] [Related]
8. Use of Epstein-Barr virus-transformed, autologous B-lymphoblastoid cells as antigen-presenting cells for establishment and maintenance of dengue virus-specific, human cytotoxic T lymphocyte clones. Livingston PG; Kurane I; Ennis FA J Virol Methods; 1997 Aug; 67(1):77-84. PubMed ID: 9274820 [TBL] [Abstract][Full Text] [Related]
9. Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells. Kannagi M; Sugamura K; Sato H; Okochi K; Uchino H; Hinuma Y J Immunol; 1983 Jun; 130(6):2942-6. PubMed ID: 6189906 [TBL] [Abstract][Full Text] [Related]
10. Generation in vitro of EBV-induced specific cytotoxic T cells in autologous serum avoids complications due to self-preferred foetal calf serum-specific T-cell cytotoxicity. Misko IS; Kane RG; Pope JH Int J Cancer; 1981; 27(4):513-9. PubMed ID: 6268554 [TBL] [Abstract][Full Text] [Related]
11. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044 [TBL] [Abstract][Full Text] [Related]
12. Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen. Misko IS; Schmidt C; Honeyman M; Soszynski TD; Sculley TB; Burrows SR; Moss DJ; Burman K Clin Exp Immunol; 1992 Jan; 87(1):65-70. PubMed ID: 1370774 [TBL] [Abstract][Full Text] [Related]
13. Stimulation with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines generates HLA class I-specific CTLs with different target cell avidity. Torsteinsdottir S; Cuomo L; Klein E; Masucci MG Cell Immunol; 1991 Oct; 137(2):501-13. PubMed ID: 1654213 [TBL] [Abstract][Full Text] [Related]
14. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice. Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263 [TBL] [Abstract][Full Text] [Related]
15. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies. van de Griend RJ; Giphart MJ; Van Krimpen BA; Bolhuis RL J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072 [TBL] [Abstract][Full Text] [Related]
16. Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines. Zarling JM; Bach FH J Exp Med; 1978 May; 147(5):1334-40. PubMed ID: 206649 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease. Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978 [TBL] [Abstract][Full Text] [Related]
18. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Torsteinsdottir S; Masucci MG; Ehlin-Henriksson B; Brautbar C; Ben Bassat H; Klein G; Klein E Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5620-4. PubMed ID: 3016710 [TBL] [Abstract][Full Text] [Related]
19. HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. Misko IS; Moss DJ; Pope JH Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4247-50. PubMed ID: 6254017 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2. Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]